- Home
- DBVT vs FTHM Comparison
DBVT vs FTHM Comparison
Compare DBVT & FTHM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DBVT
- FTHM
- Stock Information
- Founded
- DBVT 2002
- FTHM 2010
- Country
- DBVT France
- FTHM United States
- Employees
- DBVT N/A
- FTHM N/A
- Industry
- DBVT Biotechnology: Biological Products (No Diagnostic Substances)
- FTHM Real Estate
- Sector
- DBVT Health Care
- FTHM Finance
- Exchange
- DBVT Nasdaq
- FTHM Nasdaq
- Market Cap
- DBVT 67.8M
- FTHM 56.5M
- IPO Year
- DBVT N/A
- FTHM 2020
- Fundamental
- Price
- DBVT $3.12
- FTHM $1.80
- Analyst Decision
- DBVT Strong Buy
- FTHM Strong Buy
- Analyst Count
- DBVT 2
- FTHM 4
- Target Price
- DBVT $22.50
- FTHM $4.25
- AVG Volume (30 Days)
- DBVT 363.4K
- FTHM 67.2K
- Earning Date
- DBVT 11-06-2024
- FTHM 11-07-2024
- Dividend Yield
- DBVT N/A
- FTHM N/A
- EPS Growth
- DBVT N/A
- FTHM N/A
- EPS
- DBVT N/A
- FTHM N/A
- Revenue
- DBVT $12,515,000.00
- FTHM $317,515,000.00
- Revenue This Year
- DBVT N/A
- FTHM N/A
- Revenue Next Year
- DBVT $2,860.00
- FTHM $29.09
- P/E Ratio
- DBVT N/A
- FTHM N/A
- Revenue Growth
- DBVT 125.54
- FTHM N/A
- 52 Week Low
- DBVT $0.44
- FTHM $1.32
- 52 Week High
- DBVT $4.50
- FTHM $4.33
- Technical
- Relative Strength Index (RSI)
- DBVT 60.52
- FTHM 33.40
- Support Level
- DBVT $3.02
- FTHM $1.92
- Resistance Level
- DBVT $3.93
- FTHM $2.06
- Average True Range (ATR)
- DBVT 0.31
- FTHM 0.14
- MACD
- DBVT -0.06
- FTHM -0.00
- Stochastic Oscillator
- DBVT 6.76
- FTHM 5.51
About DBVT DBV Technologies S.A.
DBV Technologies SA is a clinical-stage specialty biopharmaceutical company focused on changing the field of immunotherapy by developing a novel technology platform called Viaskin. The therapeutic approach is based on epicutaneous immunotherapy or EPIT, its proprietary method of delivering biologically active compounds to the immune system through intact skin using Viaskin, an epicutaneous patch (i.e., a skin patch). Viaskin targets specific antigen-presenting immune cells in the skin, called Langerhans cells, that capture the antigen and migrate to the lymph node to activate the immune system without passage of the antigen into the bloodstream, minimizing systemic exposure in the body. Its main product candidate is Viaskin Peanut for the treatment of peanut-allergic patients.
About FTHM Fathom Holdings Inc.
Fathom Holdings Inc is a national, technology-driven, real estate services platform integrating residential brokerage, mortgage, title, insurance, and Software as a Service offering to brokerages and agents by leveraging proprietary cloud-based software, intelliAgent. The company has three reportable segments namely Real Estate Brokerage, Mortgage and Technology. The brands of the company include Fathom Realty, Dagley Insurance, Encompass Lending, intelliAgent, LiveBy, Real Results, and Verus Title.